Genetic Signatures Ltd (ASX:GSS)
A$ 0.625 -0.005 (-0.79%) Market Cap: 143.10 Mil Enterprise Value: 108.07 Mil PE Ratio: 0 PB Ratio: 2.20 GF Score: 53/100

Genetic Signatures Ltd ShareCafe Small Cap Hidden Gems Webinar Transcript

Dec 09, 2022 / 01:30AM GMT
Release Date Price: A$0.840014 (+7.50%)
John Melki
Genetic Signatures Ltd. - CEO & Director

Thanks so much, David. Something a little different for those that are new to the story. I can give you a brief introduction after our disclaimers on the next slide. But Genetic Signatures is a diagnostic company who are focused on the better detection of infectious diseases. The reason we do this are infectious diseases are a leading cause of death. They could be bacterial, they could be viral, protozoan, fungal. So in fact, we know that antibiotic-resistant bacteria can cause almost 10 deaths every minute around the globe. So better diagnostics ultimately save lives.

So we invented a technology, 3base Technology, which does enable the better detection of infectious diseases. So the technology itself dramatically simplifies the detection of these bugs, these pathogens, and multiple pathogens from the same patient sample, which is often called multiplex.

So we use our technology to make molecular or the PCR-based tests. And these tests identify infectious diseases from clinical samples. We sell these in kit form; it's under the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot